United Kingdom· GB-APID-4540011000001102
Diumide-K Continus tablets
A furosemide and potassium product containing furosemide + potassium chloride, registered in United Kingdom by Teofarma S.r.l..
Checked against NHS dm+d (United Kingdom) on
Informational only — not a medical device.
The record
At a glance
NHS dm+d (United Kingdom)- Active substance
- Furosemide + Potassium chloride
- Manufacturer
- Teofarma S.r.l.
- Country
- United Kingdom (GB)
- ATC code
- C03CB01
- ATC class
- Furosemide and potassium
- Defined daily dose
- 40 mg, O
- Reimbursed
- Not published by this register
- Source register
- NHS dm+d (United Kingdom)
- Last checked
- October 2, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C03CB01
Furosemide and potassium, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of NHS dm+d (United Kingdom). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/9988fca8-1c38-4f1f-8821-9eed5aba5ddb GET /v1/drugs/9988fca8-1c38-4f1f-8821-9eed5aba5ddb?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"apid": "4540011000001102",
"desc": "Diumide-K Continus tablets (Teofarma S.r.l.)",
"form": "Modified-release tablet",
"vpid": "4557711000001102",
"source": "dmd",
"vtm_id": "776054008",
"strength": "600 mg",
"substance": "Furosemide + Potassium chloride",
"ingredient": "Potassium chloride",
"supplier_code": "7401011000001103"
}See everything about furosemide and potassium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.